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Abstract
Background Measurement of the parathyroid hormone
(PTH) level following total thyroidectomy (TTx) may
allow prediction of postoperative hypocalcemia. We pres-
ent an algorithmic method of managing hypocalcemia pre-
emptively, based on the PTH level 1 h after operation.
Materials and methods We examined 423 consecutive
patients undergoing TTx at a single institution. A subset of
patients were managed using an algorithm involving rou-
tine postoperative oral calcium administration and the early
addition of oral calcitriol in patients with a low 1-h post-
operative PTH level. Algorithm patients were compared to
a concurrent, conventionally managed group. Outcomes
measured included serum calcium levels, symptoms of
hypocalcemia, postoperative complications, and receipt of
intravenous (IV) calcium.
Results The algorithm was applied in 135 patients, and
288 patients were managed conventionally. Critically low
calcium levels (total calcium\7.5 mg/dl [1.88 mmol/l] or
ionized calcium \0.94 mmol/l) were less common in
algorithm patients (10.6% vs. 25.3%; p\0.005). Much of
this difference was attributable to the protective impact of
the algorithm on patients undergoing TTx for cancer, 30%
of whom developed critically low calcium levels when
managed conventionally. Among patients requiring IV
calcium, algorithm patients received fewer doses (1.29 vs.
1.86; p\0.05). Low 1-h PTH levels were found in 21%
(28/133) of algorithm patients, but these did not correlate
with low calcium levels, suggesting that the algorithm
compensated adequately for temporary hypoparathyroid-
ism. No patients developed hypercalcemia.
Conclusions An algorithmic approach incorporating early
postoperative PTH levels and routine administration of oral
calcium reduces the risk of severe hypocalcemia after total
thyroidectomy.
Introduction
The management of hypocalcemia after total thyroidec-
tomy (TTx) remains a challenge. Transient hypocalcemia
is one of the most common postoperative complications of
TTx, occurring in 17–26% of patients, and it results from
direct injury to, devascularization of, or accidental removal
of the parathyroid glands [1–4]. Though early postopera-
tive hypocalcemia is reversible in the great majority of
cases, permanent hypoparathyroidism is likely much more
common than previously suspected [1].
To manage postoperative hypocalcemia, most practi-
tioners obtain serial serum calcium measurements and
respond appropriately to low levels. Recently, several
groups have advocated measurement of the parathyroid
hormone (PTH) level several hours after operation in order
to predict the development of hypocalcemia [5–13]. This
practice has not been widely adopted, nor has it been
incorporated into a standardized system of care for patients
undergoing TTx.
In the present study, we examined the impact of a
management algorithm incorporating the postoperative
PTH level as a means of preempting the development of
hypocalcemia after TTx.
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Patient selection
Data on 476 consecutive patients undergoing total thy-
roidectomy at UCLA Medical Center between January
2006 and December 2008 were used in this retrospective
cohort study. Patients with a history of hyperparathyroid-
ism, kidney transplantation, or renal failure were excluded,
as were patients undergoing emergency operations. In
addition, patients with a history of previous thyroid sur-
gery, those with nonthyroid cancers (namely cancers
invading or metastasizing to the thyroid), and those
undergoing simultaneous operations on the thymus, thy-
roglossal duct, or radical/modiﬁed radical lymph node
dissection were excluded. Using these criteria, 421 patients
were included in the ﬁnal study group. All subjects were
over the age of 18.
An algorithm for the management of post-thyroidec-
tomy calcium was implemented beginning on January 1,
2006 by select physicians in the Division of General Sur-
gery (Fig. 1). This algorithm was developed at UCLA
Medical Center and entails routine postoperative oral cal-
cium supplementation for all patients, plus the early addi-
tion of calcitriol for patients with PTH levels B15 pg/ml
(normal: 11–51 pg/ml) at 1 h after surgery. Standardized,
preprinted order sheets were created for algorithm imple-
mentation, which was carried out in conjunction with
education of residents, nurses, and ancillary staff to ensure
compliance.
Data collection
Demographic data collected included age, gender, and
race. Co-morbid conditions were deﬁned using the Deyo
modiﬁcation [9] of the Charlson co-morbidity index, which
uses International Classiﬁcation of Diseases, Ninth Revi-
sion (ICD-9-CM) codes from medical records to sum the
number of conditions from 17 diagnostic categories. Other
variables recorded included length of stay (LOS), number
of days spent in the ICU, and number of doses of intra-
venous (IV) calcium received. The aggregate postoperative
complication rate was determined using ICD-9-CM codes
for six conditions: respiratory failure, hematoma formation,
recurrent laryngeal nerve injury, wound complications, and
signs or symptoms of hypocalcemia. Since complications
were uncommon, a dichotomous variable for presence of
any complications (present/absent) was used in some
analyses. For algorithm patients, a single postoperative
calcium level was measured from blood drawn at 4:00 a.m.
on postoperative day 1, whereas non-algorithm patients
underwent serial serum calcium measurements every 6–
8 h. Serum calcium levels were grouped into the following
categories: normal (C8.7 mg/dl), low (7.5–8.6 mg/dl), and
critically low (\7.5 mg/dl). Ionized calcium levels (mmol/
l) were converted to total calcium levels (mg/dl) by mul-
tiplying by a factor of 8. This conversion yielded an
identical, consistent reference range and was valid in a
normoalbuminemic patient cohort undergoing elective
surgery. Finally, postoperative PTH levels, obtained rou-
tinely only in the algorithm group, were recorded and
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123categorized as being normal ([15 pg/ml), low-normal (10–
15 pg/ml), or low (\10 pg/ml).
Data analysis
Data were analyzed by Student’s t-test, contingency table
analysis, or one-way analysis of variance (ANOVA) for
univariate analyses. Logistic regression was applied for a
multivariate analysis. Differences were considered statis-
tically signiﬁcant for p values\0.05. Data were analyzed
with STATA/SE version 9.2 (StataCorp, College Station,
TX).
Results
The algorithm was applied in 135 patients, and 288 patients
were managed conventionally. Conventionally managed
patients received calcium replacement in response to seri-
ally drawn serum calcium levels and/or clinical manifes-
tations of hypocalcemia. Demographic characteristics of
the comparison groups are shown in Table 1. Length of
hospitalization was signiﬁcantly shorter in the algorithm
population (1.10 ± 0.48 days vs. 2.72 ± 2.1 days;
p\0.0001). When the indication for surgery was consid-
ered, non-algorithm patients were more likely to undergo
surgery for thyroid cancer (56.2% vs. 45.1%; p\0.05).
Algorithm patients were less likely to have critically low
calcium levels during hospitalization (Fig. 2). Of the total
cases during the study period, 91% were managed by 5
surgeons, all of whom did more than 35 operations. The
mean number of episodes of critical hypocalcemia was not
signiﬁcantly different when comparing high-volume ([35
cases) to low-volume (\35 cases) surgeons (0.229 vs.
0.230; p = 0.51). The protective impact of the algorithm
was more pronounced among patients undergoing TTx for
cancer, 30% of whom developed critically low calcium
levels when managed conventionally. In a multivariate
logistic regression controlling for age, sex, race, insurance
status (Medicare vs. private), co-morbidity (excluding
thyroid cancer), length of hospitalization, and thyroid
cancer status, only algorithm status predicted risk of having
at least one low or critically low calcium value. Speciﬁ-
cally, non-algorithm patients had a 2.179 greater risk of
having a low calcium value during hospitalization com-
pared with algorithm patients (95% CI 1.20–3.92;
p\0.01).
Non-algorithm and algorithm patients were equally
likely to receive IV calcium (14.9% vs. 12.8%; NS).
Among patients who received IV calcium, non-algorithm
patients received a higher average number of doses (1.86
vs. 1.29; p\0.05).
In algorithm patients, the 1-h PTH level correlated
positively with the morning calcium level on postoperative
day 1 (Fig. 3). Given the PTH cut-points assigned to dif-
ferent branches of the algorithm, we also examined the
relationship between the morning calcium level and the
PTH category (normal, low-normal, low; Fig. 4). Twenty-
one percent (28/133) of algorithm patients had low 1-h
PTH levels, of which 28.6% (8/28) developed critically
low calcium levels. Sixty-one percent (81/133) had normal
1 h PTH levels, with 5% (4/81) of those individuals
developing critically low serum calcium. A low postoper-
ative PTH level predicted low (n = 45) or critically low
(n = 8) postoperative calcium levels with a sensitivity of
93% and a speciﬁcity of 98%. A normal 1-h PTH was
associated with higher mean calcium compared with either
the low-normal or low PTH groups (p\0.0001). Calcium
values in the low versus low-normal PTH groups were not
signiﬁcantly different.
Discussion
The use of intraoperative or postoperative PTH levels to
predict hypocalcemia following TTx remains controversial.
Several groups have found that PTH levels cannot reliably
predict postoperative hypocalcemia [14, 15]. Lombardi
et al. [16] reported that parathyroid hormone measurements
less than 10 pg/ml levels alone 4 h after surgery were
unable to accurately predict hypocalcemia in 13.4% of
their study population, 2.1% of whom were symptomatic.
Other investigators support the use of PTH in identifying
patients likely to develop hypocalcemia following thy-
roidectomy [5–13]. McLeod et al. [17] showed that post-
operative PTH levels less than 12 pg/ml had a 100%
sensitivity and 92% speciﬁcity for predicting hypocalce-
mia. This was corroborated by the work of Sywak et al.
[18], which demonstrated a sensitivity of 90% and a
speciﬁcity of 84% of PTH levels from 3–10 pg/ml drawn






Mean age ± SD 50.0 ± 15.3 47.6 ± 15.7 0.14
Female (%) 223 (77.4) 112 (84.2) 0.10
Race/ethnicity (%)
White 191 (66.3) 83 (62.4) \0.05
Asian/Paciﬁc Islander 25 (8.7) 27 (20.3)
Hispanic 26 (9.0) 10 (7.5)
Black 20 (6.9) 7 (5.3)
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1234 h after surgery for predicting postoperative hypocalcemia
(as deﬁned by corrected calcium levels B2.0 mmol/l).
Similarly, in a study looking at the experiences of ﬁve
separate Australian institutions, Grodski and Serpell [19]
demonstrated a sensitivity, speciﬁcity and positive predic-
tive value of 70.7%, 92.6%, and 71.6%, respectively, for
low PTH levels (\10 ng/l) 4 h after surgery in predicting
postoperative hypocalcemia (\2.00 mmol/l). This led to
the inclusion of the routine measurement of PTH postop-
eratively in the Australian Endocrine Surgeons Guidelines
for patients undergoing total thyroidectomy [20]. In a 2008
meta-analysis of 27 papers, Grodski and Serpell [19] reit-
erated this recommendation, reporting that postoperative
PTH at any time within 24 h of total thyroidectomy can be
used to accurately predict the development of hypocalce-
mia and anticipate the need for calcium replacement, albeit
with class C evidence. In this same vein, our ﬁndings
support the use of PTH to identify those patients in whom
postoperative hypocalcemia may be anticipated.
Our practice is to administer oral calcitriol to all patients
with low and low-normal postoperative PTH levels. The
efﬁcacy of this drug treatment is supported by a number of
previous studies [21–23]. Tartaglia et al. [24] showed in
2005 that oral administration of calcium and calcitriol after
thyroidectomy signiﬁcantly decreases the risk of postop-
erative hypocalcemia. Calcitriol induces a fourfold
increase in the uptake of oral calcium [25], reducing by
half the dosage required to maintain physiologic levels in
the postoperative period. This requires less frequent dosing
and alleviates much of the nausea and constipation asso-
ciated with large amounts of oral calcium, ultimately
leading to superior patient compliance. Additionally, since
a generic form became available in 2001, calcitriol is
inexpensive ($1.20 per 0.25 mcg pill, TEVA Pharmaceu-
ticals, Petach Tikva, Israel). When used judiciously in a
sliding scale fashion, calcitriol does not lead to overtreat-
ment (to date, this practice has not resulted in any episodes
of hypercalcemia in our experience). For these reasons, we
emphasize the use of calcitriol in combination with lower
doses of oral calcium in lieu of large doses of oral calcium
alone. In a separate but related study, we found that algo-
rithmic management results in a signiﬁcantly decreased
length of hospital stay, reduced costs associated with
multiple lab draws, and a reduced need for IV calcium
administration. Furthermore, implementation of the algo-
rithm reduced the number of hospital readmissions for
postoperative complications to zero. These combined
beneﬁts yielded an average savings of $1,631 (74%) per
patient in our hospital system [26].
Fig. 2 Comparison of outcomes for all patients (a), those patients
with a non-cancer diagnosis (b), and those with a cancer diagnosis (c).
*p\0.05; **p\0.01
c
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123We noted a statistically signiﬁcant difference in the
percentages of patients undergoing TTx for a cancer versus
non-cancer diagnosis between the two study samples.
Given the need to conduct a more aggressive operation in
the treatment of malignancy, we postulated that an
increased frequency of postoperative hypoparathyroidism
would be observed in this patient population. The
hypothesis was borne out in our data, which demonstrated a
greater prevalence of critically low calcium levels among
patients undergoing TTx for cancer, with a rate of 30% in
those managed conventionally. This increased risk was
present regardless of postoperative management, suggest-
ing that, at present, our algorithm may be not aggressive
enough to prevent hypocalcemia in this patient subset. In a
randomized analysis of patients undergoing TTx with
central lymph node dissection for papillary cancer, Roh
et al. [22] demonstrated a postoperative hypocalcemia
(\8.0 mg/dl) rate of 44% in patients who received neither
oral calcium supplementation nor calcitriol. This rate
decreased to 24% with administration of oral calcium, and
8.2% with a combination of oral calcium and calcitriol.
The implication is that patients undergoing TTx for cancer
are particularly vulnerable to postoperative hypoparathy-
roidism and anticipatory measures should be routinely
employed.
The major limitation of postoperative PTH measurement
is the possibility that these values may be spuriously nor-
mal or high in a patient that subsequently develops unan-
ticipated critically low calcium levels. Among the 133
algorithm patients in our study, 81 (61%) had normal 1-h
PTH levels, and only 5% (4/81) went on to develop criti-
cally low morning calcium levels. Therefore, though we
acknowledge that spuriously normal PTH levels are occa-
sionally found, these occurrences are rare. Notably,
appropriate and timely intervention was taken in all algo-
rithm patients who ultimately required IV calcium sup-
plementation. The routine measurement of serum calcium
on the morning following operation is an additional safe-
guard that permits identiﬁcation of patients with hypo-
parathyroidism, even among those not correctly identiﬁed
by the postoperative PTH level. Furthermore, all patients
are discharged on continued calcium supplementation for
2 weeks, regardless of inpatient lab results (a low dose of
1,000 mg calcium carbonate twice daily with no calcitriol
is used for patients with completely normal PTH and cal-
cium levels). This affords a third tier of protection against
the development of hypocalcemia should it occur in a
delayed fashion following discharge, thus preventing hos-
pital readmissions.
This study is limited by its retrospective, nonrandom-
ized design. Despite these weaknesses, our data favor
implementation of an algorithmic approach to calcium
management after total thyroidectomy that is informed by
measurement of postoperative PTH level.
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